ATE420354T1 - In vivo toxikologisches screeningverfahren im hochdurchsatz - Google Patents

In vivo toxikologisches screeningverfahren im hochdurchsatz

Info

Publication number
ATE420354T1
ATE420354T1 AT00952321T AT00952321T ATE420354T1 AT E420354 T1 ATE420354 T1 AT E420354T1 AT 00952321 T AT00952321 T AT 00952321T AT 00952321 T AT00952321 T AT 00952321T AT E420354 T1 ATE420354 T1 AT E420354T1
Authority
AT
Austria
Prior art keywords
high throughput
subject
screening process
libraries
organisms
Prior art date
Application number
AT00952321T
Other languages
English (en)
Inventor
Patrick Fogarty
Original Assignee
Tosk Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/472,654 external-priority patent/US6365129B1/en
Application filed by Tosk Inc filed Critical Tosk Inc
Application granted granted Critical
Publication of ATE420354T1 publication Critical patent/ATE420354T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00952321T 1999-08-04 2000-07-31 In vivo toxikologisches screeningverfahren im hochdurchsatz ATE420354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14720099P 1999-08-04 1999-08-04
US09/472,654 US6365129B1 (en) 1999-08-04 1999-12-27 Invivo high throughput toxicology screening method

Publications (1)

Publication Number Publication Date
ATE420354T1 true ATE420354T1 (de) 2009-01-15

Family

ID=26844683

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952321T ATE420354T1 (de) 1999-08-04 2000-07-31 In vivo toxikologisches screeningverfahren im hochdurchsatz

Country Status (8)

Country Link
EP (1) EP1206567B1 (de)
AT (1) ATE420354T1 (de)
AU (1) AU781138B2 (de)
CA (1) CA2381144C (de)
DE (1) DE60041337D1 (de)
DK (1) DK1206567T3 (de)
ES (1) ES2319959T3 (de)
WO (1) WO2001011076A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2447357A1 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
EP1778858A4 (de) * 2004-01-15 2009-08-19 Univ Washington Unter verwendung von drosophila an pharmazeutika durchgeführtes screening mit hohem durchsatz

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254799A (en) * 1985-01-18 1993-10-19 Plant Genetic Systems N.V. Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants
US5180838A (en) * 1986-08-26 1993-01-19 Her Majesty The Queen As Represented By The Minister Of National Defense Of Her Majesty's Canadian Government Phototoxic compounds for use as insect control agents
DE3715114A1 (de) * 1987-05-06 1988-11-17 Krause Hans Verfahren und einrichtung zum toxizitaetsnachweis in oberflaechengewaessern sowie in trink- und brauchwasser
US5204100A (en) * 1991-02-01 1993-04-20 Ciba-Geigy Corporation Baciullus thuringiensis strains active against coleopteran insects
UA48104C2 (uk) * 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
CA2111521A1 (en) * 1993-12-15 1995-06-16 Stroud Water Research Center, Inc. Mayfly centroptilum triangulifer as a bioassay organism
US6063756A (en) * 1996-09-24 2000-05-16 Monsanto Company Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor
US6548733B2 (en) * 1998-12-21 2003-04-15 The Genetics Company, Inc. Function-based small molecular weight compound screening system in drosophila melanogaster

Also Published As

Publication number Publication date
WO2001011076A1 (en) 2001-02-15
AU781138B2 (en) 2005-05-05
DK1206567T3 (da) 2009-05-11
CA2381144A1 (en) 2001-02-15
EP1206567A4 (de) 2005-11-23
DE60041337D1 (de) 2009-02-26
AU6504300A (en) 2001-03-05
CA2381144C (en) 2012-05-01
EP1206567B1 (de) 2009-01-07
EP1206567A1 (de) 2002-05-22
ES2319959T3 (es) 2009-05-18

Similar Documents

Publication Publication Date Title
Latypov et al. Assignment of the absolute configuration of β-chiral primary alcohols by NMR: scope and limitations
Masyuko et al. Spatial organization of Pseudomonas aeruginosa biofilms probed by combined matrix-assisted laser desorption ionization mass spectrometry and confocal Raman microscopy
DE60040677D1 (de) Verbessertes toxizität-screening verfahren
MXPA00012586A (es) Glicosulfopeptidos y metodos de sintesis y uso de los mismos.
ATE346949T1 (de) Vorrichtung und verfahren zur bearbeitung biologischer proben
RU95105023A (ru) Ароматические сополиамиды, способ их получения, формованное изделие и способ его получения
Hixon et al. Nitrogen isotope (δ15N) patterns for amino acids in lemur bones are inconsistent with aridity driving megafaunal extinction in south‐western Madagascar
WO2007012695A3 (en) Tissue carbohydrate compositions and analysis thereof
EA200100533A1 (ru) Производные эритромицина, способ их получения и их применение в качестве лекарственных средств
ATE420354T1 (de) In vivo toxikologisches screeningverfahren im hochdurchsatz
DK1077218T3 (da) Peptidomimetiske forbindelser omfattende RGD-sekvenser, som er nyttige som integrininhibitorer
Dabrowski et al. Conformational studies by nuclear magentic resonance—II: The effect of steric factors on hindered rotation in enamino aldehydes and ketones
WO2000006525A3 (en) Synthesis of combinatorial libraries of compounds reminiscent of natural products
CA2523107A1 (en) Instrumentation, articles of manufacture, and analysis methods
AU2002359993A1 (en) Stable isotope-labeled amino acid, method of integrating the same into target protein, method of nmr structural analysis of protein and process for producing site-selective stable isotope-labeled fumaric acid and tartaric acid
Goff et al. Measurement of metabolite formation in single living cells of Chlamydomonas reinhardtii using synchrotron Fourier-Transform Infrared spectromicroscopy
EA200501244A1 (ru) Оксатиинкарбоксамиды
Schmid et al. Chemical composition of the organic matter in neolithic soil material as revealed by CPMAS 13C NMR spectroscopy, polysaccharide analysis, and CuO oxidation
EP1146030A3 (de) Kombinatorische Synthese und Analyse von Metallorganischen Verbindungen und Katalysatoren
ATE256120T1 (de) Reagentien für cyp2d fluoreszenztest
WO2004078131A3 (en) Evaluating effects of exposure conditions on drug samples over time
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
DE60023544D1 (de) Zusammensetzungen enthaltend eine kombination von defi und modifizierten defi und verfahren zur herstellung
BR0008665A (pt) Método papa analisar a composição de uma floramicrobiológica, ktt de teste de diagnóstico, e,usos de um kit de teste e de um método
He et al. Structural and functional comparison of mobile and recalcitrant humic fractions from agricultural soils

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties